MedTrace Logo

Diagnostic Criteria in Cardiac Sarcoidosis

NCT04737317 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-05-09

No results posted yet for this study

Summary

The purpose of the study is to evaluate the accuracy of the current diagnostic criteria of cardiac sarcoidosis.

Conditions

  • Cardiac Sarcoidosis

Interventions

DIAGNOSTIC_TEST

ECG, Echo, laboratory tests, CMR, PET-CT, Biopsy

ECG - 12 leads ECG Echo: transthoracic echocardiography laboratory tests: full blood count, electrolytes, creatinine, high sensitive cardiac troponin T, angiontesin converting enzyme, soluble interleukin-2 receptor, cardiac magnetic resonance imaging: 1.5 Tesla scanner, Conventional cine imaging and late gadolinium enhancement imaging PET-CT: 18F-fluorodeoxyglucose (FDG)- positron emission tomograph Biopsy: cardiac biopsy = endomyocardial biopsy, left and right ventricle, at least 5 specimens in formaldehyd and 3 specimens for testing of infectious agents Biopsy: extracardiac biopsy, as accessible according to imaging

Sponsors & Collaborators

  • Heart Center Leipzig - University Hospital

    lead OTHER

Principal Investigators

  • Borislav Dinov, MD · Heart Center Leipzig - University Hospital, Department Electrophysiology

  • Laura Ueberham, MD · Heart Center Leipzig - University Hospital, Department Electrophysiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-12-31
Completion
2027-01-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04737317 on ClinicalTrials.gov